NPPB and acute coronary syndrome: Wolsk et al. noted that in patients with a recent acute coronary syndrome and type 2 diabetes mellitus, BNP significantly improved C-statistics when added to risk models for each outcome examined and for cardiovascular death in a two-year follow-up study [43].